Conditions: Asthma; Valencia Autonomous Region
Intervention:
Sponsor: AstraZeneca
Not yet recruiting – verified October 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
New procedure helps asthma patients breath easier – KENS 5 TV
|
New procedure helps asthma patients breath easier
KENS 5 TV LOS ANGELES — About 22 million Americans have asthma and while most are able to control it with medication, about 15 percent of … New Treatment Helps Asthmatics Breathe Easier New Treatment Available For Asthma Sufferers |
View full post on asthma – Google News
A Study of the Safety and Efficacy of 4 Doses of BI 1744 CL Delivered Via the Respimat in Patients With Asthma.
Condition: Asthma
Interventions: Drug: Olodaterol (BI 1744); Drug: Olodaterol (BI 1744); Drug: Olodaterol (BI 1744) low; Drug: Olodaterol (BI 1744) high; Drug: Formoterol 12 mcg; Drug: Placebo
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Pilot Study for Cell Based Therapies in Patients With Asthma
Conditions: Asthma; Allergic Rhinitis
Intervention: Other: Blood donation
Sponsors: Fraunhofer-Institute of Toxicology and Experimental Medicine; Hannover Medical School
Enrolling by invitation – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Bi 671800 in Asthmatic Patients on Inhaled Corticosteroids
Condition: Asthma
Interventions: Drug: BI 671800; Drug: BI 671800; Drug: BI 671800; Drug: Placebo
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
BI671800 in Asthmatic Patients on Inhaled Corticosteroids
Condition: Asthma
Interventions: Drug: BI671800; Drug: Placebo; Drug: Montelukast
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
BI 671800 ED in Steroid-naive Asthmatic Patients
Condition: Asthma
Interventions: Drug: BI671800; Drug: Fluticasone; Drug: Placebo
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Efficacy, Safety and Pharmacokinetics of QAV680 Versus Placebo in Patients With Asthma
Condition: Asthma
Interventions: Drug: QAV680; Drug: QAV680 Placebo
Sponsor: Novartis Pharmaceuticals
Terminated – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
A Study of RO4989991 in Patients With Allergic Rhinitis
Condition: Asthma
Interventions: Drug: RO4989991; Drug: Placebo
Sponsor: Hoffmann-La Roche
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
A Randomised, Double- Blind, Placebo Controlled, Cross-over Efficacy and Safety Comparison of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for Four Weeks in Patients With Moderate Persistent Asthma
Condition: Asthma
Interventions: Drug: Placebo; Drug: Tiotropium 5 µg q.d.; Drug: Tiotropium 2.5 µg b.i.d.
Sponsors: Boehringer Ingelheim Pharmaceuticals; Pfizer
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days